Midazolam hydrochloride and Digoxin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Midazolam hydrochloride and Digoxin. Common interactions include pyrexia among females and aspartate aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people who take Midazolam hydrochloride and Digoxin have. It is created by eHealthMe based on reports of 25 people who take Midazolam hydrochloride and Digoxin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

25 people who take Midazolam hydrochloride and Digoxin together, and have interactions are studied.


What is Midazolam hydrochloride?

Midazolam hydrochloride has active ingredients of midazolam hydrochloride. It is often used in insomnia. eHealthMe is studying from 2,794 Midazolam hydrochloride users for its effectiveness, alternative drugs and more.

What is Digoxin?

Digoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 89,192 Digoxin users for its effectiveness, alternative drugs and more.

Number of Midazolam hydrochloride and Digoxin reports submitted per year:

Midazolam hydrochloride and Digoxin drug interactions.

Common Midazolam Hydrochloride and Digoxin drug interactions by gender *:

female:

  1. Pyrexia
  2. Hypotension
  3. Upper respiratory tract inflammation
  4. Abdominal pain
  5. Alpha haemolytic streptococcal infection
  6. Anaemia
  7. Cardiac failure
  8. Cardiac valve abscess
  9. Cardiac valve vegetation
  10. Cough

male:

  1. Aspartate aminotransferase increased
  2. Blood alkaline phosphatase increased
  3. Gamma-glutamyltransferase increased
  4. Hypertension
  5. Liver disorder
  6. Sepsis
  7. Shock
  8. Acute respiratory distress syndrome
  9. Alanine aminotransferase increased
  10. Angiopathy

Common Midazolam Hydrochloride and Digoxin drug interactions by age *:

0-1:

n/a

2-9:

  1. Pyrexia
  2. Hypotension
  3. Upper respiratory tract inflammation
  4. Abdominal pain
  5. Cough
  6. Gastroenteritis
  7. Influenza
  8. Rhinorrhoea
  9. Vomiting
  10. Bradycardia

10-19:

  1. Pulmonary hypertension

20-29:

  1. Alpha haemolytic streptococcal infection
  2. Anaemia
  3. Cardiac failure
  4. Cardiac valve abscess
  5. Cardiac valve vegetation
  6. Dyspnoea
  7. Ejection fraction decreased
  8. Fluid overload
  9. Hyperthyroidism
  10. Hypokinesia

30-39:

n/a

40-49:

n/a

50-59:

  1. Angiopathy
  2. Shock

60+:

  1. Aspartate aminotransferase increased
  2. Blood alkaline phosphatase increased
  3. Sepsis
  4. Spontaneous haematoma
  5. Thrombocytopenia
  6. Renal failure
  7. Acute respiratory distress syndrome
  8. Alanine aminotransferase increased
  9. Febrile neutropenia
  10. Full blood count decreased

Common conditions people have *:

  1. Sinus Tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node): 4 people, 16.00%
  2. Alpha Haemolytic Streptococcal Infection (infections with alpha-haemolytic strep bacteria are common; many strains live naturally in humans): 3 people, 12.00%
  3. Streptococcal Infection: 2 people, 8.00%
  4. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 8.00%
  5. Poor Peripheral Circulation: 2 people, 8.00%
  6. Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Midazolam hydrochloride and Digoxin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Midazolam hydrochloride and Digoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Midazolam hydrochloride interactions:

Browse all interactions between Midazolam hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Digoxin interactions:

Browse all interactions between Digoxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on midazolam hydrochloride and digoxin (the active ingredients of Midazolam hydrochloride and Digoxin, respectively), and Midazolam hydrochloride and Digoxin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Midazolam hydrochloride and Digoxin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: